Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for CGEM

Stock Name	Cullinan Oncology LLC
Ticker	CGEM(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US2300311063

Show aggregate CGEM holdings

News associated with CGEM

Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Given Average Rating of “Buy” by Brokerages: Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) have been assigned an average recommendation of “Buy” from the five research firms that are covering the stock, Marketbeat.com reports. Five equities research analysts have rated the stock with a buy rating. The average 12-month price objective among analysts that have issued ratings on the […] - 2025-08-28 02:56:53
5 Biotech Stocks To Watch Ahead Of Major Clinical Trial Data Readouts In September 2025: (RTTNews) - September 2025 could be a make-or-break month for some biotech stocks, as the companies prepare to release critical clinical trial data. - 2025-08-27 06:40:47
Morgan Stanley Has Lowered Expectations for Cullinan Therapeutics (NASDAQ:CGEM) Stock Price: Cullinan Therapeutics (NASDAQ:CGEM – Get Free Report) had its price target lowered by Morgan Stanley from $35.00 to $28.00 in a research note issued to investors on Monday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Morgan Stanley’s price objective points to a potential upside of 269.39% from the stock’s current price. […] - 2025-08-20 02:46:46
Exchange Traded Concepts LLC Has $107,000 Holdings in Cullinan Therapeutics, Inc. (NASDAQ:CGEM): Exchange Traded Concepts LLC raised its holdings in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 42.6% during the 1st quarter, HoldingsChannel reports. The fund owned 14,107 shares of the company’s stock after purchasing an additional 4,216 shares during the period. Exchange Traded Concepts LLC’s holdings in Cullinan Therapeutics were worth $107,000 as […] - 2025-06-25 04:57:01
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Sees Significant Decline in Short Interest: Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) saw a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 5,990,000 shares, a drop of 19.9% from the April 30th total of 7,480,000 shares. Currently, 16.7% of the company’s shares are short sold. Based on an […] - 2025-06-02 05:08:54
Tower Research Capital LLC TRC Grows Stock Holdings in Cullinan Therapeutics, Inc. (NASDAQ:CGEM): Tower Research Capital LLC TRC grew its stake in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 411.3% during the 4th quarter, HoldingsChannel reports. The fund owned 8,800 shares of the company’s stock after buying an additional 7,079 shares during the period. Tower Research Capital LLC TRC’s holdings in Cullinan Therapeutics were worth […] - 2025-05-09 05:55:00
Wells Fargo & Company MN Acquires 8,056 Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM): Wells Fargo & Company MN lifted its holdings in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 47.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 24,864 shares of the company’s stock after acquiring an additional 8,056 […] - 2025-05-07 04:24:54
Barclays PLC Sells 3,383 Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM): Barclays PLC lowered its holdings in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 1.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 245,231 shares of the company’s stock after selling 3,383 shares during the period. Barclays PLC’s holdings in Cullinan […] - 2025-04-30 05:50:47
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Stock Position Decreased by Legal & General Group Plc: Legal & General Group Plc decreased its position in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 7.9% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 42,808 shares of the company’s stock after selling 3,649 shares during the quarter. Legal & General Group Plc’s holdings in Cullinan Therapeutics were worth $521,000 as of […] - 2025-04-30 04:52:47
Brokerages Set Cullinan Therapeutics, Inc. (NASDAQ:CGEM) PT at $34.80: Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) has been assigned an average recommendation of “Buy” from the six brokerages that are currently covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average twelve-month price target among analysts that have covered the stock in the […] - 2025-04-30 02:34:45
23,500 Shares in Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Purchased by ExodusPoint Capital Management LP: ExodusPoint Capital Management LP bought a new stake in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm bought 23,500 shares of the company’s stock, valued at approximately $286,000. Other hedge funds and other institutional investors also recently made changes […] - 2025-04-14 05:05:19
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Holdings Raised by American Century Companies Inc.: American Century Companies Inc. raised its stake in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 11.0% during the 4th quarter, Holdings Channel reports. The institutional investor owned 100,721 shares of the company’s stock after buying an additional 10,010 shares during the period. American Century Companies Inc.’s holdings in Cullinan Therapeutics were worth […] - 2025-04-11 04:37:03
Empirical Financial Services LLC d.b.a. Empirical Wealth Management Takes Position in Cullinan Therapeutics, Inc. (NASDAQ:CGEM): Empirical Financial Services LLC d.b.a. Empirical Wealth Management bought a new position in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 11,153 shares of the company’s stock, valued at approximately $136,000. Other large investors have […] - 2025-01-31 07:37:08
Cullinan Therapeutics (NASDAQ:CGEM) Stock Price Expected to Rise, HC Wainwright Analyst Says: Cullinan Therapeutics (NASDAQ:CGEM – Get Free Report) had its price objective boosted by investment analysts at HC Wainwright from $28.00 to $33.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s price objective indicates a potential upside of 200.55% from the stock’s […] - 2025-01-31 06:38:56

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc CGEM holdings

Date	Number of CGEM Shares Held	Base Market Value of CGEM Shares	Local Market Value of CGEM Shares	Change in CGEM Shares Held	Change in CGEM Base Value	Current Price per CGEM Share Held	Previous Price per CGEM Share Held
2025-12-12 (Friday)	16,169	USD 192,734	USD 192,734	0	USD -7,438	USD 11.92	USD 12.38
2025-12-11 (Thursday)	16,169	USD 200,172	USD 200,172	0	USD -1,294	USD 12.38	USD 12.46
2025-12-10 (Wednesday)	16,169	USD 201,466	USD 201,466	0	USD 1,617	USD 12.46	USD 12.36
2025-12-09 (Tuesday)	16,169	USD 199,849	USD 199,849	0	USD -1,293	USD 12.36	USD 12.44
2025-12-08 (Monday)	16,169	USD 201,142	USD 201,142	0	USD 29,912	USD 12.44	USD 10.59
2025-12-05 (Friday)	16,169	USD 171,230	USD 171,230	0	USD 162	USD 10.59	USD 10.58
2025-12-04 (Thursday)	16,169	USD 171,068	USD 171,068	0	USD 1,293	USD 10.58	USD 10.5
2025-12-03 (Wednesday)	16,169	USD 169,775	USD 169,775	-280	USD 1,995	USD 10.5	USD 10.2
2025-12-02 (Tuesday)	16,449	USD 167,780	USD 167,780	112	USD -7,843	USD 10.2	USD 10.75
2025-12-01 (Monday)	16,337	USD 175,623	USD 175,623	0	USD -10,129	USD 10.75	USD 11.37
2025-11-28 (Friday)	16,337	USD 185,752	USD 185,752	0	USD -6,044	USD 11.37	USD 11.74
2025-11-27 (Thursday)	16,337	USD 191,796	USD 191,796	0	USD 0	USD 11.74	USD 11.74

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CGEM by Blackrock for IE00B3VWM098

Show aggregate share trades of CGEM

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-03 SELL -280 10.680 10.010 10.077 USD -2,822 9.36 Loss of -201 on sale
2025-12-02 BUY 112 11.150 10.125 10.227 USD 1,145 9.36
2025-11-25 SELL -336 12.980 11.220 11.396 USD -3,829 9.30 Loss of -703 on sale
2025-11-17 SELL -616 9.080 8.360 8.432 USD -5,194 9.30 Profit of 534 on sale
2025-11-12 SELL -56 8.490 7.720 7.797 USD -437 9.31 Profit of 85 on sale
2025-11-06 SELL -56 7.820 7.060 7.136 USD -400 9.35 Profit of 124 on sale
2025-11-05 SELL -560 7.520 7.170 7.205 USD -4,035 9.36 Profit of 1,209 on sale
2025-11-04 SELL -112 7.800 7.360 7.404 USD -829 9.37 Profit of 221 on sale
2025-11-03 SELL -112 8.770 7.760 7.861 USD -880 9.38 Profit of 170 on sale
2025-10-28 BUY 168 8.490 8.550 8.544 USD 1,435 9.41
2025-10-24 SELL -56 7.760 8.160 8.120 USD -455 9.43 Profit of 73 on sale
2025-10-15 BUY 336 8.630 8.650 8.648 USD 2,906 9.47
2025-10-02 BUY 56 5.750 6.050 6.020 USD 337 9.51
2025-09-30 BUY 112 5.930 6.055 6.042 USD 677 9.55
2025-08-21 SELL -56 7.670 7.750 7.742 USD -434 9.65 Profit of 107 on sale
2025-07-31 BUY 168 7.770 8.150 8.112 USD 1,363 9.68
2025-06-30 SELL -112 7.530 8.000 7.953 USD -891 9.92 Profit of 220 on sale
2025-06-25 SELL -56 7.920 8.000 7.992 USD -448 9.96 Profit of 110 on sale
2025-06-20 SELL -112 7.670 8.180 8.129 USD -910 10.01 Profit of 211 on sale
2025-05-23 BUY 56 7.810 7.860 7.855 USD 440 10.26
2025-05-19 SELL -56 7.710 7.770 7.764 USD -435 10.34 Profit of 144 on sale
2025-05-15 SELL -168 7.240 7.750 7.699 USD -1,293 10.39 Profit of 453 on sale
2025-05-12 SELL -56 7.910 8.130 8.108 USD -454 10.47 Profit of 132 on sale
2025-05-09 SELL -56 7.540 8.005 7.959 USD -446 10.50 Profit of 142 on sale
2025-04-30 SELL -56 8.280 8.405 8.392 USD -470 10.65 Profit of 127 on sale
2025-04-24 SELL -112 8.140 8.411 8.384 USD -939 10.76 Profit of 266 on sale
2025-04-17 SELL -56 7.890 7.989 7.979 USD -447 10.90 Profit of 164 on sale
2025-04-15 SELL -168 7.800 8.095 8.066 USD -1,355 10.97 Profit of 488 on sale
2025-04-14 SELL -168 7.740 7.970 7.947 USD -1,335 11.01 Profit of 514 on sale
2025-04-09 SELL -224 7.790 8.100 8.069 USD -1,807 11.12 Profit of 683 on sale
2025-04-07 SELL -392 7.250 7.390 7.376 USD -2,891 11.21 Profit of 1,503 on sale
2025-04-04 SELL -560 7.410 7.615 7.594 USD -4,253 11.25 Profit of 2,049 on sale
2025-03-31 BUY 56 7.570 7.900 7.867 USD 441 11.39
2025-03-19 SELL -112 8.650 8.920 8.893 USD -996 11.71 Profit of 316 on sale
2025-03-14 SELL -336 8.790 9.010 8.988 USD -3,020 11.83 Profit of 954 on sale
2025-03-13 SELL -114 8.920 9.380 9.334 USD -1,064 11.87 Profit of 289 on sale
2025-03-12 SELL -1,938 9.080 9.190 9.179 USD -17,789 11.91 Profit of 5,294 on sale
2025-03-07 SELL -114 8.710 9.090 9.052 USD -1,032 12.06 Profit of 343 on sale
2025-03-06 SELL -171 8.510 8.620 8.609 USD -1,472 12.12 Profit of 600 on sale
2025-03-03 SELL -57 8.000 8.635 8.572 USD -489 12.31 Profit of 213 on sale
2025-02-28 SELL -41,041 8.490 8.680 8.661 USD -355,456 12.37 Profit of 152,329 on sale
2025-02-26 SELL -164 8.450 8.705 8.679 USD -1,423 12.50 Profit of 627 on sale
2025-02-25 SELL -492 8.560 8.830 8.803 USD -4,331 12.57 Profit of 1,854 on sale
2025-02-18 BUY 820 9.260 9.825 9.768 USD 8,010 12.90
2025-02-13 BUY 164 9.590 9.960 9.923 USD 1,627 13.10
2025-02-12 BUY 164 9.890 9.950 9.944 USD 1,631 13.16
2025-02-11 BUY 492 9.810 10.270 10.224 USD 5,030 13.23
2025-02-06 BUY 1,476 10.350 10.700 10.665 USD 15,742 13.43
2025-01-27 BUY 164 10.300 10.880 10.822 USD 1,775 14.07
2024-12-30 BUY 820 12.200 12.280 12.272 USD 10,063 14.39
2024-12-06 BUY 656 13.060 13.210 13.195 USD 8,656 14.55
2024-12-05 BUY 164 12.440 12.990 12.935 USD 2,121 14.62
2024-12-04 BUY 820 12.960 13.025 13.018 USD 10,675 14.68
2024-11-29 BUY 820 13.450 13.570 13.558 USD 11,118 14.86
2024-11-27 BUY 656 13.090 13.110 13.108 USD 8,599 15.02
2024-11-26 BUY 164 12.770 13.200 13.157 USD 2,158 15.12
2024-11-21 BUY 820 12.220 12.840 12.778 USD 10,478 15.54
2024-11-20 BUY 492 12.580 13.515 13.422 USD 6,603 15.71
2024-11-18 BUY 1,963 13.450 14.145 14.076 USD 27,630 16.01
2024-11-12 BUY 1,304 16.020 17.503 17.355 USD 22,631 16.01
2024-11-08 BUY 815 16.020 16.450 16.407 USD 13,372 16.01
2024-11-07 BUY 2,445 15.580 17.190 17.029 USD 41,636 16.04
2024-11-06 BUY 326 16.480 17.000 16.948 USD 5,525 16.01
2024-10-31 BUY 163 15.550 16.210 16.144 USD 2,631 16.11
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-03	SELL	-280	10.680	10.010	10.077	USD -2,822	9.36 Loss of -201 on sale
2025-12-02	BUY	112	11.150	10.125	10.227	USD 1,145	9.36
2025-11-25	SELL	-336	12.980	11.220	11.396	USD -3,829	9.30 Loss of -703 on sale
2025-11-17	SELL	-616	9.080	8.360	8.432	USD -5,194	9.30 Profit of 534 on sale
2025-11-12	SELL	-56	8.490	7.720	7.797	USD -437	9.31 Profit of 85 on sale
2025-11-06	SELL	-56	7.820	7.060	7.136	USD -400	9.35 Profit of 124 on sale
2025-11-05	SELL	-560	7.520	7.170	7.205	USD -4,035	9.36 Profit of 1,209 on sale
2025-11-04	SELL	-112	7.800	7.360	7.404	USD -829	9.37 Profit of 221 on sale
2025-11-03	SELL	-112	8.770	7.760	7.861	USD -880	9.38 Profit of 170 on sale
2025-10-28	BUY	168	8.490	8.550	8.544	USD 1,435	9.41
2025-10-24	SELL	-56	7.760	8.160	8.120	USD -455	9.43 Profit of 73 on sale
2025-10-15	BUY	336	8.630	8.650	8.648	USD 2,906	9.47
2025-10-02	BUY	56	5.750	6.050	6.020	USD 337	9.51
2025-09-30	BUY	112	5.930	6.055	6.042	USD 677	9.55
2025-08-21	SELL	-56	7.670	7.750	7.742	USD -434	9.65 Profit of 107 on sale
2025-07-31	BUY	168	7.770	8.150	8.112	USD 1,363	9.68
2025-06-30	SELL	-112	7.530	8.000	7.953	USD -891	9.92 Profit of 220 on sale
2025-06-25	SELL	-56	7.920	8.000	7.992	USD -448	9.96 Profit of 110 on sale
2025-06-20	SELL	-112	7.670	8.180	8.129	USD -910	10.01 Profit of 211 on sale
2025-05-23	BUY	56	7.810	7.860	7.855	USD 440	10.26
2025-05-19	SELL	-56	7.710	7.770	7.764	USD -435	10.34 Profit of 144 on sale
2025-05-15	SELL	-168	7.240	7.750	7.699	USD -1,293	10.39 Profit of 453 on sale
2025-05-12	SELL	-56	7.910	8.130	8.108	USD -454	10.47 Profit of 132 on sale
2025-05-09	SELL	-56	7.540	8.005	7.959	USD -446	10.50 Profit of 142 on sale
2025-04-30	SELL	-56	8.280	8.405	8.392	USD -470	10.65 Profit of 127 on sale
2025-04-24	SELL	-112	8.140	8.411	8.384	USD -939	10.76 Profit of 266 on sale
2025-04-17	SELL	-56	7.890	7.989	7.979	USD -447	10.90 Profit of 164 on sale
2025-04-15	SELL	-168	7.800	8.095	8.066	USD -1,355	10.97 Profit of 488 on sale
2025-04-14	SELL	-168	7.740	7.970	7.947	USD -1,335	11.01 Profit of 514 on sale
2025-04-09	SELL	-224	7.790	8.100	8.069	USD -1,807	11.12 Profit of 683 on sale
2025-04-07	SELL	-392	7.250	7.390	7.376	USD -2,891	11.21 Profit of 1,503 on sale
2025-04-04	SELL	-560	7.410	7.615	7.594	USD -4,253	11.25 Profit of 2,049 on sale
2025-03-31	BUY	56	7.570	7.900	7.867	USD 441	11.39
2025-03-19	SELL	-112	8.650	8.920	8.893	USD -996	11.71 Profit of 316 on sale
2025-03-14	SELL	-336	8.790	9.010	8.988	USD -3,020	11.83 Profit of 954 on sale
2025-03-13	SELL	-114	8.920	9.380	9.334	USD -1,064	11.87 Profit of 289 on sale
2025-03-12	SELL	-1,938	9.080	9.190	9.179	USD -17,789	11.91 Profit of 5,294 on sale
2025-03-07	SELL	-114	8.710	9.090	9.052	USD -1,032	12.06 Profit of 343 on sale
2025-03-06	SELL	-171	8.510	8.620	8.609	USD -1,472	12.12 Profit of 600 on sale
2025-03-03	SELL	-57	8.000	8.635	8.572	USD -489	12.31 Profit of 213 on sale
2025-02-28	SELL	-41,041	8.490	8.680	8.661	USD -355,456	12.37 Profit of 152,329 on sale
2025-02-26	SELL	-164	8.450	8.705	8.679	USD -1,423	12.50 Profit of 627 on sale
2025-02-25	SELL	-492	8.560	8.830	8.803	USD -4,331	12.57 Profit of 1,854 on sale
2025-02-18	BUY	820	9.260	9.825	9.768	USD 8,010	12.90
2025-02-13	BUY	164	9.590	9.960	9.923	USD 1,627	13.10
2025-02-12	BUY	164	9.890	9.950	9.944	USD 1,631	13.16
2025-02-11	BUY	492	9.810	10.270	10.224	USD 5,030	13.23
2025-02-06	BUY	1,476	10.350	10.700	10.665	USD 15,742	13.43
2025-01-27	BUY	164	10.300	10.880	10.822	USD 1,775	14.07
2024-12-30	BUY	820	12.200	12.280	12.272	USD 10,063	14.39
2024-12-06	BUY	656	13.060	13.210	13.195	USD 8,656	14.55
2024-12-05	BUY	164	12.440	12.990	12.935	USD 2,121	14.62
2024-12-04	BUY	820	12.960	13.025	13.018	USD 10,675	14.68
2024-11-29	BUY	820	13.450	13.570	13.558	USD 11,118	14.86
2024-11-27	BUY	656	13.090	13.110	13.108	USD 8,599	15.02
2024-11-26	BUY	164	12.770	13.200	13.157	USD 2,158	15.12
2024-11-21	BUY	820	12.220	12.840	12.778	USD 10,478	15.54
2024-11-20	BUY	492	12.580	13.515	13.422	USD 6,603	15.71
2024-11-18	BUY	1,963	13.450	14.145	14.076	USD 27,630	16.01
2024-11-12	BUY	1,304	16.020	17.503	17.355	USD 22,631	16.01
2024-11-08	BUY	815	16.020	16.450	16.407	USD 13,372	16.01
2024-11-07	BUY	2,445	15.580	17.190	17.029	USD 41,636	16.04
2024-11-06	BUY	326	16.480	17.000	16.948	USD 5,525	16.01
2024-10-31	BUY	163	15.550	16.210	16.144	USD 2,631	16.11

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CGEM

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	91,713	0	453,137	20.2%
2025-09-18	29,909	64	374,322	8.0%
2025-09-17	29,113	561	152,081	19.1%
2025-09-16	41,765	2	156,366	26.7%
2025-09-15	69,037	556	213,450	32.3%
2025-09-12	76,084	0	383,502	19.8%
2025-09-11	66,615	867	581,520	11.5%
2025-09-10	55,097	0	308,725	17.8%
2025-09-09	106,491	0	278,733	38.2%
2025-09-08	44,979	0	172,182	26.1%
2025-09-05	92,584	2,960	314,975	29.4%
2025-09-04	218,977	13,252	745,971	29.4%
2025-09-03	59,535	0	162,544	36.6%
2025-09-02	30,215	0	107,256	28.2%
2025-08-29	28,955	0	102,690	28.2%
2025-08-28	39,008	0	89,895	43.4%
2025-08-27	50,544	0	153,481	32.9%
2025-08-26	38,684	3	378,657	10.2%
2025-08-25	17,620	0	58,531	30.1%
2025-08-22	73,100	0	173,435	42.1%
2025-08-21	27,559	0	85,312	32.3%
2025-08-20	37,739	0	91,418	41.3%
2025-08-19	37,960	0	83,526	45.4%
2025-08-18	77,212	0	180,135	42.9%
2025-08-15	37,996	0	114,067	33.3%
2025-08-14	15,179	0	186,706	8.1%
2025-08-13	25,903	0	130,511	19.8%
2025-08-12	44,973	0	119,053	37.8%
2025-08-11	41,962	128	103,183	40.7%
2025-08-08	67,304	2,573	153,714	43.8%
2025-08-07	80,102	176	173,936	46.1%
2025-08-06	21,373	0	51,516	41.5%
2025-08-05	22,741	0	58,650	38.8%
2025-08-04	26,114	0	93,276	28.0%
2025-08-01	38,240	579	76,874	49.7%
2025-07-31	35,027	58	68,864	50.9%
2025-07-30	80,500	0	739,899	10.9%
2025-07-29	58,393	9	130,459	44.8%
2025-07-28	27,557	0	46,548	59.2%
2025-07-25	21,736	176	36,209	60.0%
2025-07-24	54,730	18	130,095	42.1%
2025-07-23	77,967	0	133,955	58.2%
2025-07-22	49,802	0	89,671	55.5%
2025-07-21	27,480	0	40,112	68.5%
2025-07-18	29,606	0	50,251	58.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE